TP53 and neoplasm: Using targeted deep sequencing of TP53 coding regions (exons 2 to 11 and flanking splicing sites), we demonstrated a 24% to 36% concordance fraction between variants detected in cfDNA from archived serum and paired FFPE ESCC tumor tissue.